Skip to main content
    D

    DocGo Inc (DCGO)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.18
    -0.01 (-3.53%)

    Market Cap: $20.55M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    DocGo Inc (DCGO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    DocGo (DCGO) has a market cap of $20.55M and an enterprise value of $12.52M. It kept -65.69% of revenue as net income over the last 12 months. It holds $8.03M more cash than debt, 39.10% of its market cap.

    Total Valuation

    Enterprise value is 39.10% below the market cap, as cash exceeds debt.

    Market Cap$20.55M
    Enterprise Value$12.52M
    Latest price (Nov 17, 2026)$0.18

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.14% in the quarter ended Sep 30, 2026 and shrank 1.54% a year over 2 years.

    Shares Outstanding98.94M
    Shares Change (YoY)+1.16%
    Shares Change (QoQ)+0.14%
    Share Count Growth (2Y CAGR)-1.54%

    Valuation Ratios

    P/B Ratio0.2x
    P/TBV Ratio0.2x

    Price Statistics

    The stock is down 82.88% over 52 weeks and trades 40.00% below its 50-day average.

    Beta (1Y)1.66
    52-Week Change-82.88%
    1-Month Change-28.13%
    3-Month Change-56.43%
    6-Month Change-67.67%
    Total Return (1Y)-82.88%
    Total Return (3Y CAGR)-68.38%
    Total Return (5Y CAGR)-54.97%
    Max Drawdown (1Y)-83.04%
    Max Drawdown (3Y)-97.03%
    Sharpe Ratio (1Y)-1.81
    Correlation with SPY (1Y)0.25
    50-Day Average$0.30
    200-Day Average$0.54
    52-Week Range$0.18 to $1.10
    RSI (14 Days)28.8
    Average Volume (20 Days)806.79K

    Price chart

    Financial Position

    Current assets cover 1.38x current liabilities, and total debt is 0.11x shareholder equity.

    Current Ratio1.38x
    Quick Ratio1.38x
    Debt / Equity0.11x

    Returns and Efficiency

    Return on invested capital is -140.82% over the last 12 months, against a 5-year average of -20.13%.

    Return on Equity (ROE)-185.87%
    Return on Assets (ROA)-112.32%
    Return on Invested Capital (ROIC)-140.82%
    Return on Capital Employed (ROCE)-173.56%
    ROE (5Y Average)-21.77%
    ROA (5Y Average)-14.29%
    ROIC (5Y Average)-20.13%
    Asset Turnover1.13x
    Receivables Turnover3.51x

    Scores

    DCGO has an Altman Z-Score of -2.93, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-2.93
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $297.34M over the last 12 months is down 19.22% from the 12 months before.

    Revenue$297.34M
    Revenue Growth (YoY)-19.22%
    Gross Profit$73.90M
    Operating Income-$158.50M
    Pretax Income-$164.44M
    Net Income-$195.32M
    EBITDA-$152.03M
    EBIT-$163.58M
    Reported EPS (TTM)-$2.02

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 60.43% of the $173.90M in total assets.

    Cash and Equivalents$19.11M
    Total Debt$11.07M
    Net Cash$8.03M
    Net Cash Per Share$0.08
    Working Capital$30.05M
    Shareholder Equity$105.08M
    Book Value Per Share$1.06
    Tangible Book Value$103.19M
    Tangible Book Per Share$1.04
    Total Assets$173.90M
    Total Liabilities$94.92M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $4.41M of capital spending, operating cash flow left -$32.40M of free cash flow.

    Operating Cash Flow-$27.99M
    Capital Expenditures$4.41M
    Free Cash Flow-$32.40M
    FCF Per Share-$0.33
    Depreciation and Amortization$11.54M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -53.30%, against a 5-year average of -7.68%.

    Gross Margin24.85%
    Operating Margin-53.30%
    Pretax Margin-55.30%
    Net Margin-65.69%
    EBITDA Margin-51.13%
    EBIT Margin-55.01%
    FCF Margin-10.90%
    Gross Margin (5Y Average)33.23%
    Operating Margin (5Y Average)-7.68%
    Net Margin (5Y Average)-8.83%

    Growth

    Revenue fell 9.90% a year over 3 years.

    Revenue Growth (3Y CAGR)-9.90%
    Revenue Growth (5Y CAGR)+27.91%
    FCF Growth (3Y CAGR)+5.22%
    Book Value Per Share Growth (2Y CAGR)-28.17%
    Tangible Book Per Share Growth (2Y CAGR)-15.15%

    Revenue and profit by year

    Dividends and Yields

    DCGO does not pay a dividend. Its free cash flow yield is -178.75%.

    FCF Yield-178.75%
    Buyback Yield0.00%

    Peer Position

    Against 9 similar companies, DCGO has the lowest ROIC.

    ROIC-140.82% vs 1.15% median
    Revenue Growth (Trailing 4 Quarters, YoY)-19.22% vs +10.87% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -2.05% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-2.05%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DCGO

    What is DCGO's market cap?

    DocGo has a market cap of $20.55M. Its enterprise value, which adds debt and subtracts cash, is $12.52M.

    How many shares of DCGO are outstanding?

    DocGo has 98.94M shares outstanding. The count is up 1.16% from a year earlier.

    Does DCGO pay a dividend?

    No. DocGo does not pay a dividend.

    How much debt does DCGO have?

    DocGo has $11.07M of total debt and $19.11M of cash and equivalents, a net cash position of $8.03M.